RxDoctor Payments Data

Jeremie Axe, MD

Orthopaedic Surgery · Newark, DENPI 1093979692

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 65.6% of it on its own, with 26 other manufacturers making up the rest. Among orthopaedic surgery clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$179,041in general payments, 2019–2025

Across 481 payments — averaging $372.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$117K
  • Stryker$41K
  • Liberty Surgical Inc.$5K
  • Medical Device Business Services, Inc.$5K
  • Eclipse Technology Solutions Inc.$4K
  • Smith+Nephew$1K
  • plus $5K from 21 others

What the payments were for

  • Consulting fees$103,57258%
  • Speaking & faculty fees$40,89623%
  • Travel & lodging$14,4968%
  • Food & beverage$17,67710%
  • Education$2,4001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex151$117,452
Stryker(2 entities)71$40,996
Liberty Surgical Inc.42$5,414
Medical Device Business Services, Inc.4$5,007
Eclipse Technology Solutions Inc.54$4,077
Smith+Nephew25$1,340
Davol Inc.14$898
Amgen64$878
Johnson & Johnson(2 entities)11$588
Pacira Therapeutics, Inc.9$552
Integrity Orthopaedics, Inc.5$459
Zimmer Biomet4$268
Zynex Medical, Inc.1$228
Baxter Healthcare3$126
Pacira Pharmaceuticals Incorporated5$124
Axogen2$122
Medacta USA, Inc.1$110
Conformis, Inc.1$94
Bioventus LLC5$93
BD2$46
Embody, Inc.1$40
FX Shoulder Solutions, Inc1$34
Vertex1$32
KCI USA, Inc.1$17
Ferring Pharmaceuticals Inc.1$16
Pfizer1$16
Synergy Orthopedics, LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$179,041 in reported general payments places this provider in the 95th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$752,134
Medicare patients
994
Services billed
22,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam185$1,098
Methylprednisolone47$291
Gabapentin81$252
Cephalexin73$131
Cyclobenzaprine Hcl18$101

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →